首页>
外国专利>
CANCER BIOMARKERS FOR DURABLE CLINICAL BENEFIT
CANCER BIOMARKERS FOR DURABLE CLINICAL BENEFIT
展开▼
机译:持久性临床益处的癌症生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present disclosure concerns methods of treating cancer with neoantigenic peptides such that durable clinical benefits are obtained, and compositions and methods for determining whether DCB can be predicted or assessed for a patient to be treated with a therapeutic comprising neoantigen.
展开▼